Utah Medical Products, Inc.
UTMD
$71.10
$0.390.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.15% | 1.48% | -2.47% | -13.68% | 0.23% |
| Total Depreciation and Amortization | -64.97% | -9.47% | -1.17% | 1.45% | 5.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 204.76% | -164.62% | -69.77% | 441.27% | 53.68% |
| Change in Net Operating Assets | -1,026.24% | -263.95% | -67.30% | 130.23% | -203.82% |
| Cash from Operations | -55.52% | -10.58% | -10.34% | 34.98% | -35.64% |
| Capital Expenditure | -3.08% | -19.27% | -303.70% | 47.06% | 72.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.08% | -19.27% | -303.70% | 47.06% | 72.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 39.06% | 87.12% | -52.22% | 81.27% | -8.26% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.20% | -1.23% | 1.11% | 1.30% | 1.57% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.66% | 43.33% | -20.11% | 63.44% | -5.90% |
| Foreign Exchange rate Adjustments | 70.75% | -330.43% | 175.41% | -123.46% | 69.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.61% | 10.81% | -28.69% | 282.20% | -428.37% |